首页> 外国专利> Peptides and Mixtures for Immunotherapy of Chronic Lymphocytic Leukemia and Other Cancers

Peptides and Mixtures for Immunotherapy of Chronic Lymphocytic Leukemia and Other Cancers

机译:用于慢性淋巴细胞白血病和其他癌症的免疫疗法的肽和混合物

摘要

Current inventions involve peptides.Protein.Nucleic acids and cells used in immunotherapy. Especially,The current invention is immunotherapy for cancer. The invention also relates to cucumber entries of T lymphocytes related to tumors.Individually or in combination with other cancer-related peptidesFor instanceThey can be used as active drugs in vaccine components to stimulate the anti-tumor immune response.Or stimulating pre-existing T lymphocytes and transferring them to patients Peptides that bind to molecules in larger histocompatibility complexes.Or a peptide like thisIt could also be a target for antibodies.T-soluble lymphocyte receptors,There are other binding molecules.
机译:当前的发明涉及用于免疫治疗的肽,蛋白质,核酸和细胞。特别地,本发明是用于癌症的免疫疗法。本发明还涉及与肿瘤有关的T淋巴细胞的黄瓜进入。单独地或与其他与癌症有关的肽结合使用,例如,它们可用作疫苗成分中的活性药物以刺激抗肿瘤免疫反应。或刺激预先存在的T淋巴细胞。并将其转移给患者结合到更大的组织相容性复合物中的分子的肽。或者像这样的肽也可能是抗体的靶标。T可溶性淋巴细胞受体,还有其他结合分子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号